ReviewClinical transplantation and research2025
Technical overview of pediatric liver transplantation for congenital absence of the portal vein: a collective review of six cases at a single center.
Review in Clinical transplantation and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital absence of the portal vein (CAPV) is a rare vascular anomaly in which mesenteric venous blood bypasses the liver and drains directly into systemic circulation. Liver transplantation (LT) is considered for patients who develop severe complications or do not respond to medical therapy. Because splanchnic venous anatomy varies markedly among patients with CAPV, portal vein (PV) reconstruction must be customized to individual vascular patterns. We reviewed surgical approaches to PV reconstruction in six pediatric LT cases with CAPV reported from a single institution. Patients ranged in age from 3 years 5 months to 12 years at the time of LT. Portocaval shunts (PCS) were classified as extrahepatic in five cases and intrahepatic in one case. Portal hypertension was identified in three patients. Sources of portal inflow included the PCS vein, native extrahepatic PV trunk, enlarged PV collateral vein, pericholedochal collateral vein, and confluence of the mesenteric-splenic vein. All patients recovered without vascular complications and remained alive, with follow-up ranging from 3 to 11 years. In conclusion, CAPV is frequently associated with complex vascular anomalies. Careful preoperative and intraoperative assessment is essential, and PV reconstruction must be individually tailored with anatomically appropriate techniques to achieve successful outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.